优化痛风治疗:对当前和新兴的尿素药物进行全面审查
Dan Kaufmann1, Nathorn Chaiyakunapruk2, Naomi Schlesinger3
1Division of Rheumatology, Department of Medicine, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, 84132 Utah, United States.
痛风是一种常见的炎症性关节炎,用尿酸降低疗法 (ULT) 治疗. 本综述重点介绍的是增加尿酸脏分泌的尿酸酸药物,有助于痛风管理.
科学领域:
- 类风湿病学 类风湿病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 痛风是最常见的炎症性关节炎,影响5.1%的美国成年人.
- 它源于尿酸升高导致单酸盐晶体沉积和自身炎症.
- 血清尿酸水平与痛风的严重程度相关,因此尿酸降低疗法 (ULT) 是必不可少的.
研究的目的:
- 审查用于痛风治疗的已批准和正在研究的尿素酸药物.
- 讨论增强脏尿酸分泌的药物.
- 突出运输体在尿素酸药物开发中的作用.
主要方法:
- 关于尿素酸剂的文献综述.
- 对已批准的和正在开发的尿素酸药物的分析.
- 讨论这些药物向的脏尿酸运输体.
主要成果:
- 超极致药物包括丁氧化还原酶抑制剂,尿素素药和尿.
- 普罗贝尼西德是美国FDA批准的唯一尿素酸剂;其他如博马龙和多提努拉德在其他地方使用.
- 像URAT1,GLUT9,OAT1,OAT3和OAT4这样的脏转运体是尿素酸药物的关键目标.
结论:
- 尿酸药物对于通过增加尿酸分泌来治疗痛风至关重要.
- 了解脏尿酸转运体对于开发新型尿酸酸疗法至关重要.
- 本综述提供了用于痛风治疗的尿素酸剂的全面概述.
更多相关视频
07:45Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Phase II Reactions: Glucuronidation
Renal Drug Excretion: Tubular Secretion
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
